Biota Message Board - Msg: 2650107

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biota

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A.J. Mullen who wrote (12)	11/5/1997 10:22:00 PM
From: Craig McNeill	of 46

Gilead certainly appears to have a brighter future based upon pipleline. I looked more into BTA today, and quite honestly, while I like the stock at these levels I'm not inclined to purchase because the ADR market is too thin. My broker (Lehman) couldn't even identify the market makers...Bloomberg didn't have any listed either. While I could buy the A$ listed stock, it was going to be expensive and difficult to track. Until there is more liquidity, I'll track BTA but will not purchase. I agree with you point on over-extending themselves too. They should focus on several therapies/diseases and bring them to market. For such a small company they seem to be spread, IMHO, a little too thin. But then again, I'm not technical either, and perhaps there are synergies between some of the research & products. Good luck. cm

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next